Repro Med Systems Inc
NASDAQ:KRMD

Watchlist Manager
Repro Med Systems Inc Logo
Repro Med Systems Inc
NASDAQ:KRMD
Watchlist
Price: 3.52 USD -1.68% Market Closed
Market Cap: 161.4m USD
Have any thoughts about
Repro Med Systems Inc?
Write Note

Repro Med Systems Inc
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Repro Med Systems Inc
Capital Expenditures Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Repro Med Systems Inc
NASDAQ:KRMD
Capital Expenditures
-$814.6k
CAGR 3-Years
8%
CAGR 5-Years
-11%
CAGR 10-Years
-16%
Becton Dickinson and Co
NYSE:BDX
Capital Expenditures
-$725m
CAGR 3-Years
15%
CAGR 5-Years
5%
CAGR 10-Years
-1%
Boston Scientific Corp
NYSE:BSX
Capital Expenditures
-$780m
CAGR 3-Years
-15%
CAGR 5-Years
-8%
CAGR 10-Years
-10%
Stryker Corp
NYSE:SYK
Capital Expenditures
-$634m
CAGR 3-Years
-9%
CAGR 5-Years
-1%
CAGR 10-Years
-11%
Abbott Laboratories
NYSE:ABT
Capital Expenditures
-$2.2B
CAGR 3-Years
-5%
CAGR 5-Years
-6%
CAGR 10-Years
-7%
Intuitive Surgical Inc
NASDAQ:ISRG
Capital Expenditures
-$1.2B
CAGR 3-Years
-67%
CAGR 5-Years
-29%
CAGR 10-Years
-33%
No Stocks Found

Repro Med Systems Inc
Glance View

Market Cap
160.8m USD
Industry
Health Care

Repro-Med Systems, Inc. engages in the design, manufacture, and market of proprietary medical devices. The company is headquartered in Chester New York, New York and currently employs 77 full-time employees. The company is focused on the developing, manufacturing, and commercializing of specialty infusion solutions. The firm's products include the FREEDOM Infusion Systems, which consist of the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgHFlo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. The FREEDOM System operates at a lower pressure and maintains a balance between what a patient’s subcutaneous tissues can absorb and what the system delivers. The firm performs product assembly, calibration, pre- and post-assembly quality control inspection and testing, and final packaging for all its products at its Chester, New York facility.

KRMD Intrinsic Value
3.16 USD
Overvaluation 10%
Intrinsic Value
Price

See Also

What is Repro Med Systems Inc's Capital Expenditures?
Capital Expenditures
-814.6k USD

Based on the financial report for Dec 31, 2023, Repro Med Systems Inc's Capital Expenditures amounts to -814.6k USD.

What is Repro Med Systems Inc's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-16%

Over the last year, the Capital Expenditures growth was 71%. The average annual Capital Expenditures growth rates for Repro Med Systems Inc have been 8% over the past three years , -11% over the past five years , and -16% over the past ten years .

Back to Top